img

Global Prostate-Specific Antigen (PSA) Test Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Prostate-Specific Antigen (PSA) Test Market Research Report 2024

Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), is a glycoprotein enzyme encoded in humans by the KLK3 gene.

The PSA test measures the level of PSA in a man’s blood. For this test, a blood sample is sent to a laboratory for analysis. The results are usually reported as nanograms of PSA per milliliter (ng/mL) of blood.
According to MRAResearch’s new survey, global Prostate-Specific Antigen (PSA) Test market is projected to reach US$ 628.6 million in 2033, increasing from US$ 511 million in 2022, with the CAGR of 2.9% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Prostate-Specific Antigen (PSA) Test market research.
The major players in global PSA Test market include Abbott, Siemens Healthcare, DiaSorin, etc. The top 3 players occupy about 50% shares of the global market. North America and Europe are main markets, they occupy over 80% of the global market. CLIA is the main type, with a share over 70%. Screening is the key application, which holds a share about 80%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Prostate-Specific Antigen (PSA) Test market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Abbott
Siemens Healthcare
DiaSorin
Roche
Beckman Coulter
PerkinElmer
Tosoh
Ortho Clinical
Fujirebio
Mediwatch (LABORIE)
BodiTech
Segment by Type
CLIA
ELISA
Other

Segment by Application


Screening
Post-treatment Monitoring
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Prostate-Specific Antigen (PSA) Test report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate-Specific Antigen (PSA) Test Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 CLIA
1.2.3 ELISA
1.2.4 Other
1.3 Market by Application
1.3.1 Global Prostate-Specific Antigen (PSA) Test Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Screening
1.3.3 Post-treatment Monitoring
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prostate-Specific Antigen (PSA) Test Market Perspective (2018-2033)
2.2 Prostate-Specific Antigen (PSA) Test Growth Trends by Region
2.2.1 Global Prostate-Specific Antigen (PSA) Test Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Prostate-Specific Antigen (PSA) Test Historic Market Size by Region (2018-2023)
2.2.3 Prostate-Specific Antigen (PSA) Test Forecasted Market Size by Region (2024-2033)
2.3 Prostate-Specific Antigen (PSA) Test Market Dynamics
2.3.1 Prostate-Specific Antigen (PSA) Test Industry Trends
2.3.2 Prostate-Specific Antigen (PSA) Test Market Drivers
2.3.3 Prostate-Specific Antigen (PSA) Test Market Challenges
2.3.4 Prostate-Specific Antigen (PSA) Test Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate-Specific Antigen (PSA) Test Players by Revenue
3.1.1 Global Top Prostate-Specific Antigen (PSA) Test Players by Revenue (2018-2023)
3.1.2 Global Prostate-Specific Antigen (PSA) Test Revenue Market Share by Players (2018-2023)
3.2 Global Prostate-Specific Antigen (PSA) Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prostate-Specific Antigen (PSA) Test Revenue
3.4 Global Prostate-Specific Antigen (PSA) Test Market Concentration Ratio
3.4.1 Global Prostate-Specific Antigen (PSA) Test Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate-Specific Antigen (PSA) Test Revenue in 2022
3.5 Prostate-Specific Antigen (PSA) Test Key Players Head office and Area Served
3.6 Key Players Prostate-Specific Antigen (PSA) Test Product Solution and Service
3.7 Date of Enter into Prostate-Specific Antigen (PSA) Test Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate-Specific Antigen (PSA) Test Breakdown Data by Type
4.1 Global Prostate-Specific Antigen (PSA) Test Historic Market Size by Type (2018-2023)
4.2 Global Prostate-Specific Antigen (PSA) Test Forecasted Market Size by Type (2024-2033)
5 Prostate-Specific Antigen (PSA) Test Breakdown Data by Application
5.1 Global Prostate-Specific Antigen (PSA) Test Historic Market Size by Application (2018-2023)
5.2 Global Prostate-Specific Antigen (PSA) Test Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Prostate-Specific Antigen (PSA) Test Market Size (2018-2033)
6.2 North America Prostate-Specific Antigen (PSA) Test Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Prostate-Specific Antigen (PSA) Test Market Size by Country (2018-2023)
6.4 North America Prostate-Specific Antigen (PSA) Test Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prostate-Specific Antigen (PSA) Test Market Size (2018-2033)
7.2 Europe Prostate-Specific Antigen (PSA) Test Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Prostate-Specific Antigen (PSA) Test Market Size by Country (2018-2023)
7.4 Europe Prostate-Specific Antigen (PSA) Test Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size (2018-2033)
8.2 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size by Region (2018-2023)
8.4 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Prostate-Specific Antigen (PSA) Test Market Size (2018-2033)
9.2 Latin America Prostate-Specific Antigen (PSA) Test Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Prostate-Specific Antigen (PSA) Test Market Size by Country (2018-2023)
9.4 Latin America Prostate-Specific Antigen (PSA) Test Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size (2018-2033)
10.2 Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size by Country (2018-2023)
10.4 Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Prostate-Specific Antigen (PSA) Test Introduction
11.1.4 Abbott Revenue in Prostate-Specific Antigen (PSA) Test Business (2018-2023)
11.1.5 Abbott Recent Development
11.2 Siemens Healthcare
11.2.1 Siemens Healthcare Company Detail
11.2.2 Siemens Healthcare Business Overview
11.2.3 Siemens Healthcare Prostate-Specific Antigen (PSA) Test Introduction
11.2.4 Siemens Healthcare Revenue in Prostate-Specific Antigen (PSA) Test Business (2018-2023)
11.2.5 Siemens Healthcare Recent Development
11.3 DiaSorin
11.3.1 DiaSorin Company Detail
11.3.2 DiaSorin Business Overview
11.3.3 DiaSorin Prostate-Specific Antigen (PSA) Test Introduction
11.3.4 DiaSorin Revenue in Prostate-Specific Antigen (PSA) Test Business (2018-2023)
11.3.5 DiaSorin Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Prostate-Specific Antigen (PSA) Test Introduction
11.4.4 Roche Revenue in Prostate-Specific Antigen (PSA) Test Business (2018-2023)
11.4.5 Roche Recent Development
11.5 Beckman Coulter
11.5.1 Beckman Coulter Company Detail
11.5.2 Beckman Coulter Business Overview
11.5.3 Beckman Coulter Prostate-Specific Antigen (PSA) Test Introduction
11.5.4 Beckman Coulter Revenue in Prostate-Specific Antigen (PSA) Test Business (2018-2023)
11.5.5 Beckman Coulter Recent Development
11.6 PerkinElmer
11.6.1 PerkinElmer Company Detail
11.6.2 PerkinElmer Business Overview
11.6.3 PerkinElmer Prostate-Specific Antigen (PSA) Test Introduction
11.6.4 PerkinElmer Revenue in Prostate-Specific Antigen (PSA) Test Business (2018-2023)
11.6.5 PerkinElmer Recent Development
11.7 Tosoh
11.7.1 Tosoh Company Detail
11.7.2 Tosoh Business Overview
11.7.3 Tosoh Prostate-Specific Antigen (PSA) Test Introduction
11.7.4 Tosoh Revenue in Prostate-Specific Antigen (PSA) Test Business (2018-2023)
11.7.5 Tosoh Recent Development
11.8 Ortho Clinical
11.8.1 Ortho Clinical Company Detail
11.8.2 Ortho Clinical Business Overview
11.8.3 Ortho Clinical Prostate-Specific Antigen (PSA) Test Introduction
11.8.4 Ortho Clinical Revenue in Prostate-Specific Antigen (PSA) Test Business (2018-2023)
11.8.5 Ortho Clinical Recent Development
11.9 Fujirebio
11.9.1 Fujirebio Company Detail
11.9.2 Fujirebio Business Overview
11.9.3 Fujirebio Prostate-Specific Antigen (PSA) Test Introduction
11.9.4 Fujirebio Revenue in Prostate-Specific Antigen (PSA) Test Business (2018-2023)
11.9.5 Fujirebio Recent Development
11.10 Mediwatch (LABORIE)
11.10.1 Mediwatch (LABORIE) Company Detail
11.10.2 Mediwatch (LABORIE) Business Overview
11.10.3 Mediwatch (LABORIE) Prostate-Specific Antigen (PSA) Test Introduction
11.10.4 Mediwatch (LABORIE) Revenue in Prostate-Specific Antigen (PSA) Test Business (2018-2023)
11.10.5 Mediwatch (LABORIE) Recent Development
11.11 BodiTech
11.11.1 BodiTech Company Detail
11.11.2 BodiTech Business Overview
11.11.3 BodiTech Prostate-Specific Antigen (PSA) Test Introduction
11.11.4 BodiTech Revenue in Prostate-Specific Antigen (PSA) Test Business (2018-2023)
11.11.5 BodiTech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Prostate-Specific Antigen (PSA) Test Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of CLIA
Table 3. Key Players of ELISA
Table 4. Key Players of Other
Table 5. Global Prostate-Specific Antigen (PSA) Test Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Prostate-Specific Antigen (PSA) Test Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Prostate-Specific Antigen (PSA) Test Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Prostate-Specific Antigen (PSA) Test Market Share by Region (2018-2023)
Table 9. Global Prostate-Specific Antigen (PSA) Test Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Prostate-Specific Antigen (PSA) Test Market Share by Region (2024-2033)
Table 11. Prostate-Specific Antigen (PSA) Test Market Trends
Table 12. Prostate-Specific Antigen (PSA) Test Market Drivers
Table 13. Prostate-Specific Antigen (PSA) Test Market Challenges
Table 14. Prostate-Specific Antigen (PSA) Test Market Restraints
Table 15. Global Prostate-Specific Antigen (PSA) Test Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Prostate-Specific Antigen (PSA) Test Market Share by Players (2018-2023)
Table 17. Global Top Prostate-Specific Antigen (PSA) Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate-Specific Antigen (PSA) Test as of 2022)
Table 18. Ranking of Global Top Prostate-Specific Antigen (PSA) Test Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Prostate-Specific Antigen (PSA) Test Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Prostate-Specific Antigen (PSA) Test Product Solution and Service
Table 22. Date of Enter into Prostate-Specific Antigen (PSA) Test Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Prostate-Specific Antigen (PSA) Test Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Prostate-Specific Antigen (PSA) Test Revenue Market Share by Type (2018-2023)
Table 26. Global Prostate-Specific Antigen (PSA) Test Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Prostate-Specific Antigen (PSA) Test Revenue Market Share by Type (2024-2033)
Table 28. Global Prostate-Specific Antigen (PSA) Test Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Prostate-Specific Antigen (PSA) Test Revenue Market Share by Application (2018-2023)
Table 30. Global Prostate-Specific Antigen (PSA) Test Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Prostate-Specific Antigen (PSA) Test Revenue Market Share by Application (2024-2033)
Table 32. North America Prostate-Specific Antigen (PSA) Test Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Prostate-Specific Antigen (PSA) Test Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Prostate-Specific Antigen (PSA) Test Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Prostate-Specific Antigen (PSA) Test Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Prostate-Specific Antigen (PSA) Test Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Prostate-Specific Antigen (PSA) Test Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Prostate-Specific Antigen (PSA) Test Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Prostate-Specific Antigen (PSA) Test Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Prostate-Specific Antigen (PSA) Test Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size by Country (2024-2033) & (US$ Million)
Table 47. Abbott Company Detail
Table 48. Abbott Business Overview
Table 49. Abbott Prostate-Specific Antigen (PSA) Test Product
Table 50. Abbott Revenue in Prostate-Specific Antigen (PSA) Test Business (2018-2023) & (US$ Million)
Table 51. Abbott Recent Development
Table 52. Siemens Healthcare Company Detail
Table 53. Siemens Healthcare Business Overview
Table 54. Siemens Healthcare Prostate-Specific Antigen (PSA) Test Product
Table 55. Siemens Healthcare Revenue in Prostate-Specific Antigen (PSA) Test Business (2018-2023) & (US$ Million)
Table 56. Siemens Healthcare Recent Development
Table 57. DiaSorin Company Detail
Table 58. DiaSorin Business Overview
Table 59. DiaSorin Prostate-Specific Antigen (PSA) Test Product
Table 60. DiaSorin Revenue in Prostate-Specific Antigen (PSA) Test Business (2018-2023) & (US$ Million)
Table 61. DiaSorin Recent Development
Table 62. Roche Company Detail
Table 63. Roche Business Overview
Table 64. Roche Prostate-Specific Antigen (PSA) Test Product
Table 65. Roche Revenue in Prostate-Specific Antigen (PSA) Test Business (2018-2023) & (US$ Million)
Table 66. Roche Recent Development
Table 67. Beckman Coulter Company Detail
Table 68. Beckman Coulter Business Overview
Table 69. Beckman Coulter Prostate-Specific Antigen (PSA) Test Product
Table 70. Beckman Coulter Revenue in Prostate-Specific Antigen (PSA) Test Business (2018-2023) & (US$ Million)
Table 71. Beckman Coulter Recent Development
Table 72. PerkinElmer Company Detail
Table 73. PerkinElmer Business Overview
Table 74. PerkinElmer Prostate-Specific Antigen (PSA) Test Product
Table 75. PerkinElmer Revenue in Prostate-Specific Antigen (PSA) Test Business (2018-2023) & (US$ Million)
Table 76. PerkinElmer Recent Development
Table 77. Tosoh Company Detail
Table 78. Tosoh Business Overview
Table 79. Tosoh Prostate-Specific Antigen (PSA) Test Product
Table 80. Tosoh Revenue in Prostate-Specific Antigen (PSA) Test Business (2018-2023) & (US$ Million)
Table 81. Tosoh Recent Development
Table 82. Ortho Clinical Company Detail
Table 83. Ortho Clinical Business Overview
Table 84. Ortho Clinical Prostate-Specific Antigen (PSA) Test Product
Table 85. Ortho Clinical Revenue in Prostate-Specific Antigen (PSA) Test Business (2018-2023) & (US$ Million)
Table 86. Ortho Clinical Recent Development
Table 87. Fujirebio Company Detail
Table 88. Fujirebio Business Overview
Table 89. Fujirebio Prostate-Specific Antigen (PSA) Test Product
Table 90. Fujirebio Revenue in Prostate-Specific Antigen (PSA) Test Business (2018-2023) & (US$ Million)
Table 91. Fujirebio Recent Development
Table 92. Mediwatch (LABORIE) Company Detail
Table 93. Mediwatch (LABORIE) Business Overview
Table 94. Mediwatch (LABORIE) Prostate-Specific Antigen (PSA) Test Product
Table 95. Mediwatch (LABORIE) Revenue in Prostate-Specific Antigen (PSA) Test Business (2018-2023) & (US$ Million)
Table 96. Mediwatch (LABORIE) Recent Development
Table 97. BodiTech Company Detail
Table 98. BodiTech Business Overview
Table 99. BodiTech Prostate-Specific Antigen (PSA) Test Product
Table 100. BodiTech Revenue in Prostate-Specific Antigen (PSA) Test Business (2018-2023) & (US$ Million)
Table 101. BodiTech Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostate-Specific Antigen (PSA) Test Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Prostate-Specific Antigen (PSA) Test Market Share by Type: 2022 VS 2033
Figure 3. CLIA Features
Figure 4. ELISA Features
Figure 5. Other Features
Figure 6. Global Prostate-Specific Antigen (PSA) Test Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Prostate-Specific Antigen (PSA) Test Market Share by Application: 2022 VS 2033
Figure 8. Screening Case Studies
Figure 9. Post-treatment Monitoring Case Studies
Figure 10. Other Case Studies
Figure 11. Prostate-Specific Antigen (PSA) Test Report Years Considered
Figure 12. Global Prostate-Specific Antigen (PSA) Test Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Prostate-Specific Antigen (PSA) Test Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Prostate-Specific Antigen (PSA) Test Market Share by Region: 2022 VS 2033
Figure 15. Global Prostate-Specific Antigen (PSA) Test Market Share by Players in 2022
Figure 16. Global Top Prostate-Specific Antigen (PSA) Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate-Specific Antigen (PSA) Test as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Prostate-Specific Antigen (PSA) Test Revenue in 2022
Figure 18. North America Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Prostate-Specific Antigen (PSA) Test Market Share by Country (2018-2033)
Figure 20. United States Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Prostate-Specific Antigen (PSA) Test Market Share by Country (2018-2033)
Figure 24. Germany Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Share by Region (2018-2033)
Figure 32. China Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Prostate-Specific Antigen (PSA) Test Market Share by Country (2018-2033)
Figure 40. Mexico Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Share by Country (2018-2033)
Figure 44. Turkey Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Abbott Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2018-2023)
Figure 47. Siemens Healthcare Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2018-2023)
Figure 48. DiaSorin Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2018-2023)
Figure 49. Roche Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2018-2023)
Figure 50. Beckman Coulter Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2018-2023)
Figure 51. PerkinElmer Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2018-2023)
Figure 52. Tosoh Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2018-2023)
Figure 53. Ortho Clinical Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2018-2023)
Figure 54. Fujirebio Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2018-2023)
Figure 55. Mediwatch (LABORIE) Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2018-2023)
Figure 56. BodiTech Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed